Enalapril, an ACE inhibitor widely used in humans for blood pressure management, was selected for testing because of its beneficial effects on hypertension, obesity, diabetes, and congestive heart failure in aged humans [38–40]. The gene discussed is ACE; the disease is obesity disorder.